Tag: CPhI Japan

Pricing system reform and generics trend apparent at CPhI Japan 2018

Increased international generic API companies and suppliers are reported at next month’s CPhI Japan 2018, traditionally an innovative drug focussed market, due to recent changes in the country.

Japanese pharma – no longer ‘lost in translation’

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increased internationalisation.